Skip to content
Clinical ResearchResearch compoundATC · D10BA01Rx · Prescription only (Rx), dermatologist protocol + pregnancy prevention

Isotretinoin

13-cis-retinoic acid (Roche Roaccutane). Gold standard for severe nodulocystic acne. FDA category X due to severe teratogenicity – iPLEDGE program mandatory.

Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Isotretinoin vial

Related comparisons

Isotretinoin vs Tretinoin

WHAT IS ISOTRETINOIN?

Detailed overview

Isotretinoin (Roche Roaccutane / Accutane, FDA 1982) is the gold-standard treatment for severe nodulocystic acne. 13-cis-retinoic acid (vitamin A metabolite) causes sebaceous gland atrophy, sebum production reduction, and P. acnes growth inhibition. EXTREME TERATOGENICITY (FDA category X) – every female patient must enroll in pregnancy prevention program (USA: iPLEDGE, EU: similar national programs). 2 negative pregnancy tests before start, 2 forms contraception mandatory, monthly testing. Layton 2009 (PMID 20436884) 6-month course produces sustained remission in ~80% of cases. Side effect profile SIGNIFICANT: dryness (mouth, eye, skin, lip), muscle pain, liver function disturbance, depression risk.

ATC code

D10BA01

Prescription

Prescription only (Rx), iPLEDGE/pregnancy prevention

Mechanism

Retinoid (RAR agonist), sebaceous gland suppression

Half-life

~21 h (active 4-oxo metabolite ~24 h)

Onset

4-8 weeks (initial), 15-20 weeks full course

Data console

Lab data

/lab/molecular-data.jsonLIVE
> ATC codeD10BA01
> PrescriptionPrescription only (Rx), dermatologist protocol + pregnancy prevention
> MechanismRetinoid receptor (RAR) partial agonist. Sebaceous gland at…
> Half-life~21 h (parent), 24 h (active 4-oxo-isotretinoin)
> Onset4-8 weeks (initial improvement), 4-6 months (full course)
> Bioavailability~25% (oral, fasted; >2× higher with high-fat meal – FDA Accutane label)

Safety

Side effects, stop signs, contraindications

Side effects · 7

  • Cheilitis and generalized mucocutaneous dryness in nearly all patients (~90%): chapped lips, dry nose (nosebleeds), dry eyes and skin.
  • Psychiatric effects: low mood, depression, rarely suicidal ideation – an official FDA warning; any mood change must be reported immediately.
  • Blood lipid rise: triglycerides and cholesterol can increase (rare pancreatitis risk), so monthly lipid panel monitoring is mandatory.
  • Hepatic dysfunction: elevated ALT/AST transaminases, so regular liver-enzyme checks are required during the course.
  • Musculoskeletal complaints: muscle and joint pain, back pain, especially with physical exertion; common during treatment.
  • Increased photosensitivity and an initial acne flare (purging) early in the course, plus slower wound healing.
  • Rare but serious: pseudotumor cerebri (benign intracranial hypertension) with persistent headache and visual disturbance, plus reduced night vision.

Contraindications · 3

  • PREGNANCY (FDA category X – severe craniofacial, CV, CNS malformations)
  • Childbearing age without contraception
  • Hypervitaminosis A, severe hepatic disease

Related Pharmaceuticals

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about Isotretinoin?

Educational drug info from official sources (PubMed, FDA, EMA). Does NOT replace medical consultation or the SmPC. Talk to your doctor!

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: June 19, 2026

The information here is for educational and scientific purposes only. Medication use requires medical consultation and a prescription. The indications, dose ranges, and side effects listed here do NOT replace the official Summary of Product Characteristics (SmPC) or consultation with a physician. Do not start or stop any medication on your own. In an emergency, call your local emergency number.